Genetics of COPA syndrome

Area of Science:

• Immunology
• Genetics
• Cell Biology

Background:

• Inborn errors of immunity can cause immunodeficiency and immune dysregulation (autoinflammation, autoimmunity, malignancy).
• COPA syndrome is a recently identified monogenic disorder of immune dysregulation caused by mutations in the COPA gene.
• The COPA gene encodes a protein crucial for reverse vesicular transport from the Golgi apparatus to the endoplasmic reticulum (ER).

Purpose of the Study:

• To review the clinical and molecular aspects of COPA syndrome.
• To elucidate the role of COPA gene mutations in immune dysregulation and ER stress.
• To highlight COPA syndrome as a novel primary immunodeficiency with a distinct phenotype.

Main Methods:

• Review of existing literature on COPA syndrome.
• Analysis of clinical presentations including interstitial lung disease, pulmonary hemorrhage, and arthritis.
• Examination of immunological features such as autoantibody formation, elevated IL-1β and IL-6, and increased Th17 cells.
• Discussion of the molecular pathophysiology involving aberrant protein transport, ER stress, and impaired autophagy.

Main Results:

• COPA syndrome presents with a unique phenotype of interstitial lung disease, pulmonary hemorrhage, and arthritis.
• Immunological findings include autoantibody production and elevated inflammatory cytokines (IL-1β, IL-6).
• Mutations in COPA disrupt vesicular transport, leading to ER stress and contributing to immune dysregulation.

Conclusions:

• COPA syndrome represents a novel primary immunodeficiency linked to the COPA gene.
• Defective protein transport and subsequent ER stress are key mechanisms in COPA syndrome pathogenesis.
• Understanding COPA syndrome offers insights into the interplay between protein trafficking, ER stress, and immune system function.